Supreme Court Lets Takeda's Actos Patent Stand
The U.S. Supreme Court has snuffed Alphapharm Pty Ltd.'s hopes of soon launching a generic version of Takeda Pharmaceutical Co.'s blockbuster diabetes drug Actos, refusing last week to review an appeals...To view the full article, register now.
Already a subscriber? Click here to view full article